메뉴 건너뛰기




Volumn 6, Issue 3, 2002, Pages 271-274

What are the challenges of translating positive trial results in severe sepsis into clinical practice? A media roundtable debate, 18 March 2002, Brussels, Belgium

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C;

EID: 0035998351     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1503     Document Type: Conference Paper
Times cited : (3)

References (19)
  • 8
    • 0026874127 scopus 로고
    • Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
    • American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
    • (1992) Crit. Care Med , vol.20 , pp. 864-874
  • 15
    • 84872261616 scopus 로고    scopus 로고
    • Fundamental Critical Care Support Course
  • 16
    • 84872266289 scopus 로고    scopus 로고
    • ALERT (Acute Life Threatening Emergencies - Recognition & Treatment) course
    • (2001)
    • Smith, G.1
  • 19
    • 0001699143 scopus 로고    scopus 로고
    • Cost-effectiveness of drotrecogin alfa (activated) (Xigris™) in severe sepsis
    • (2002) Crit. Care Med , vol.30 , pp. 492-493


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.